Pharmaceutical composition for treating gout and gouty arthritis

A technology for gouty arthritis and composition, applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of easy recurrence, adverse reactions of toxic and side effects, small toxic and side effects, etc., and achieves easy acceptance, significant curative effect, and reduced The effect of blood uric acid

Inactive Publication Date: 2014-04-02
广西南宁科冠医药科技开发有限公司
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] The purpose of the present invention is to provide a medicine that can reduce blood uric acid, prevent and treat gout, and treat gouty arthritis, aiming at the situation that gout and gouty arthritis are prone to repeated attacks, and commonly used western medicines often cause some toxic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A method for the treatment of gout, gouty arthritis pharmaceutical composition capsules, comprising the following steps:

[0038] (1) Weigh the components according to the following parts by weight: Gynostemma pentaphyllum 20kg, Luo Han Guo 30kg, Lycium barbarum 30kg, Sargassum 15kg, Speranthema 15kg, Gurixiang 12kg, Qiannianjian 5kg, Guizhi 10kg, Astragalus 10kg, Salvia miltiorrhiza 10kg, Chuan Achyranthes bidentata 5kg is crushed into fine powder, and then passed through an 80-mesh sieve to obtain a mixed medicinal powder;

[0039] (2) Add 8 times the amount of water to the mixed medicinal powder obtained in step (1), heat and extract twice for 2 hours each time, filter, combine the filtrate, concentrate the filtrate into a thick paste, add an appropriate amount of starch, dry, and pulverize to obtain dry cream powder;

[0040] (3) Take the dry paste powder obtained in step 2, wrap it with 6 times the amount of beta-cyclodextrin to form a beta-cyclodextrin inclusion ...

Embodiment 2

[0042] A method for the treatment of gout, gouty arthritis pharmaceutical composition capsules, comprising the following steps:

[0043] 1. Weigh the components according to the following parts by weight: Gynostemma 30kg, Luo Han Guo 20kg, Fructus Lycium barbarum 20kg, Sargassum 20kg, Speranthema 35kg, Gurixiang 10kg, Qiannianjian 10kg, Guizhi 15kg, Astragalus 15kg, Salvia miltiorrhiza 8KGg, Sichuan Achyranthes bidentata 10kg; crushed into fine powder, then passed through 80 mesh sieve to obtain mixed medicinal powder;

[0044] (2) Add 12 times the amount of water to the mixed medicinal powder obtained in step (1), heat and extract 3 times, 1 hour each time, filter, combine the filtrate, concentrate the filtrate into a thick paste, add the poria cocos powder under step 2 and appropriate amount Starch, dried, crushed to obtain dry cream powder;

[0045] (3) Take the dry paste powder obtained in step 2, add 10 times the amount of beta-cyclodextrin to form a beta-cyclodextrin in...

Embodiment 3

[0047] A method for the treatment of gout, gouty arthritis pharmaceutical composition capsules, comprising the following steps:

[0048] (1) Weigh the components according to the following parts by weight: Gynostemma pentaphyllum 25kg, Luo Han Guo 25kg, Lycium barbarum 25kg, Sargassum 25kg, Speranthema 20kg, Gurixiang 15kg, Qiannianjian 8kg, Guizhi 12kg, Astragalus 12kg, Salvia miltiorrhiza 9kg, Chuan Achyranthes bidentata 10kg is crushed into fine powder, passed through an 80-mesh sieve to obtain a mixed medicinal powder;

[0049] (2) Add 10 times the amount of water to the mixed medicinal powder obtained in step (1), heat and extract twice, 2 hours each time, filter, combine the filtrate, concentrate the filtrate into a thick paste, add the poria cocos powder under step 2 and appropriate amount Starch, dried, crushed to obtain dry cream powder;

[0050] (3) Take the dry cream powder obtained in step 2, add 8 times the amount of beta-cyclodextrin to form a beta-cyclodextrin ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating gout and gouty arthritis. The invention is characterized in that the pharmaceutical composition is prepared from the following components in parts by weight: 20-30 parts of gynostemma pentaphyllum, 20-30 parts of fructus momordicae, 20-30 parts of wolfberry fruit, 15-25 parts of sargentgloryvine, 15-25 parts of american lopseed, 10-15 parts of murraya jasminorage, 5-10 parts of homalomena rhizoma, 10-15 parts of cassia twig, 10-15 parts of radix astragali, 8-10 parts of radix salviae miltiorrhizae and 5-10 parts of radix cyathulae. The pharmaceutical composition has the effects of dispersing blood stasis, removing turbidity, expelling wind and removing dampness, eliminating rheumatism, alleviating pain, harmonizing the stomach and tonifying vital energy, has favorable curative effect on gout, gouty arthritis and the like, can enhance the immunity of organisms, and has no toxic or side effect.

Description

[0001] technical field [0002] The invention relates to the field of medicines, in particular to a pharmaceutical composition for treating gout and gouty arthritis. Background technique [0003] Gout is a group of diseases caused by the increase of uric acid production and / or the decrease of uric acid excretion caused by the disorder of purine metabolism. Modern medicine has made it clear that the onset of gout is directly related to the increase of uric acid concentration in the blood caused by the disorder of purine metabolism in the body. A serious metabolic disease of health. Gouty arthritis is due to the increase of uric acid in the body, resulting in the deposition of urate in the joint capsule, synovium, cartilage, bone or / and accompanied by urate deposition in the kidney, subcutaneous, and other tissues, causing tissue damage and inflammation. Elevated blood uric acid is an important feature of gouty arthritis. [0004] The prior art mainly adopts western medicine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/888A61P19/06A61P19/02
Inventor 杨建国粱梦雪
Owner 广西南宁科冠医药科技开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products